Benzinga's Weekend M&A Chatter

Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 3 through Sunday June 5, 2016:
Twitter, Yahoo Said to have Discussed Potential MergerThe Rumor
:

Twitter
TWTR
met with Yahoo
YHOO
management, including CEO Marissa Mayer, to discuss a potential merger, according to sources as reported by the
NY Post
on Friday. The meeting is said to have taken place several weeks ago, but Twitter decided to not to proceed with the bidding process. Yahoo and Twitter declined comment. Verizon
VZ
is still seen as the front runner to acquire Yahoo's core internet business, with AT&T
T
and Dan Gilber also potential buyers. Yahoo fell 15% Friday to close at $36.60.
McKesson Considering Separation of IT UnitThe Rumor
:

McKesson Corp.
MCK
is considering separation its information-technology business, according to sources as reported by the
Wall Street Journal
late Thursday. The unit is said to be valued at more than $5 billion. McKesson closed at $186.46 on Friday, down $1.33.
AstraZeneca, Teva, Biogen, Allergan Said to be Potential Bidders for Acadia
Loading...
Loading...
The Rumor
:

AstraZeneca
AZN
is said to be among potential bidders for Acadia Pharmaceuticals, according to a report from the UK
Daily Mail
late Friday. Sources say Acadia investors would not accept less than $60 per share. Other potential buyers include Teva Pharmaceutical Industries
TEVA
, Biogen
BIIB
and Allergan
AGN
, the report said. Acadia closed at $36.07 on Friday and traded up 3.5% after-hours.
Bayer Chairman Said to have Held Secret Meeting With Investors Regarding Monsanto BidThe Rumor
:

Monsanto
MON
shares spiked higher Friday, on a tweet from Fox Business' Charlie Gasparino indicating that the Bayer
BAYRY
Chariman Werner Baumann held a secret meeting on Thursday, to discuss the bid to acquire the U.S. agricultural company. Sources who attended the meeting said Baumann is willing to increase the offer for Monsanto. Bayer offered $122 per share for Monanto last month, but shares have remained around $111 due in part to regulatory concerns and pressure from Bayer shareholders, who have been less than enthusiastic regarding the bid. Monsanto closed at $111.00 on Friday, up $0.64.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsRumorsM&AMoversHealth CareHealth Care Distributors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...